Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs VAISHALI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA VAISHALI PHARMA AUROBINDO PHARMA/
VAISHALI PHARMA
 
P/E (TTM) x 23.0 25.7 89.3% View Chart
P/BV x 2.4 4.6 52.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   VAISHALI PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
VAISHALI PHARMA
Mar-23
AUROBINDO PHARMA/
VAISHALI PHARMA
5-Yr Chart
Click to enlarge
High Rs715194 368.8%   
Low Rs39764 617.4%   
Sales per share (Unadj.) Rs424.266.0 642.4%  
Earnings per share (Unadj.) Rs32.96.3 525.6%  
Cash flow per share (Unadj.) Rs54.16.7 803.6%  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.131.3 1,465.7%  
Shares outstanding (eoy) m585.9410.55 5,553.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.0 67.1%   
Avg P/E ratio x16.920.6 82.0%  
P/CF ratio (eoy) x10.319.1 53.6%  
Price / Book Value ratio x1.24.1 29.4%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,7531,361 23,935.0%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22313 270,734.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554697 35,679.5%  
Other income Rs m2,90622 13,036.8%   
Total revenues Rs m251,460719 34,977.4%   
Gross profit Rs m37,07094 39,528.4%  
Depreciation Rs m12,4465 246,940.5%   
Interest Rs m1,40523 6,227.0%   
Profit before tax Rs m26,12588 29,533.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,84922 30,532.8%   
Profit after tax Rs m19,27766 29,189.1%  
Gross profit margin %14.913.5 110.8%  
Effective tax rate %26.225.4 103.4%   
Net profit margin %7.89.5 81.8%  
BALANCE SHEET DATA
Current assets Rs m214,599727 29,530.2%   
Current liabilities Rs m114,938321 35,841.9%   
Net working cap to sales %40.158.3 68.8%  
Current ratio x1.92.3 82.4%  
Inventory Days Days2118 114.8%  
Debtors Days Days662,809 2.3%  
Net fixed assets Rs m176,66861 290,429.6%   
Share capital Rs m586105 555.6%   
"Free" reserves Rs m267,813224 119,425.9%   
Net worth Rs m268,399330 81,401.9%   
Long term debt Rs m6,19052 11,841.6%   
Total assets Rs m392,125788 49,790.5%  
Interest coverage x19.64.9 398.2%   
Debt to equity ratio x00.2 14.5%  
Sales to assets ratio x0.60.9 71.7%   
Return on assets %5.311.2 46.9%  
Return on equity %7.220.0 35.9%  
Return on capital %10.029.1 34.5%  
Exports to sales %33.725.2 133.7%   
Imports to sales %15.37.8 196.8%   
Exports (fob) Rs m83,703176 47,686.1%   
Imports (cif) Rs m38,06054 70,234.0%   
Fx inflow Rs m85,483176 48,700.1%   
Fx outflow Rs m41,44755 75,345.0%   
Net fx Rs m44,036121 36,538.3%   
CASH FLOW
From Operations Rs m23,86811 220,995.4%  
From Investments Rs m-39,7783 -1,410,549.6%  
From Financial Activity Rs m18,144-17 -104,758.1%  
Net Cashflow Rs m2,298-4 -61,929.9%  

Share Holding

Indian Promoters % 48.8 26.6 183.2%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 0.0 -  
FIIs % 20.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 73.4 65.6%  
Shareholders   241,944 9,181 2,635.3%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs VAISHALI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs VAISHALI PHARMA Share Price Performance

Period Aurobindo Pharma VAISHALI PHARMA S&P BSE HEALTHCARE
1-Day 1.82% -4.34% 1.18%
1-Month 5.96% -4.79% -0.75%
1-Year 113.07% -3.51% 61.82%
3-Year CAGR 7.78% 62.23% 18.16%
5-Year CAGR 7.18% 39.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the VAISHALI PHARMA share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of VAISHALI PHARMA the stake stands at 26.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of VAISHALI PHARMA .

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

VAISHALI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of VAISHALI PHARMA .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.